Amneal Pharmaceuticals Inc (AMRX)
8.19
-0.16
(-1.92%)
USD |
NASDAQ |
Sep 27, 16:00
8.19
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Free Cash Flow: 176.08M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | 176.08M |
| March 31, 2024 | 124.24M |
| December 31, 2023 | 276.39M |
| September 30, 2023 | 137.50M |
| June 30, 2023 | 113.83M |
| March 31, 2023 | -5.182M |
| December 31, 2022 | -25.50M |
| September 30, 2022 | 53.27M |
| June 30, 2022 | 79.76M |
| March 31, 2022 | 161.41M |
| December 31, 2021 | 189.18M |
| September 30, 2021 | 219.34M |
| Date | Value |
|---|---|
| June 30, 2021 | 175.96M |
| March 31, 2021 | 407.64M |
| December 31, 2020 | 312.82M |
| September 30, 2020 | 183.00M |
| June 30, 2020 | 282.52M |
| March 31, 2020 | 71.28M |
| December 31, 2019 | -95.73M |
| September 30, 2019 | 199.56M |
| June 30, 2019 | 97.35M |
| March 31, 2019 | 19.21M |
| December 31, 2018 | 153.14M |
Free Cash Flow Range, Past 5 Years
-95.73M
Minimum
Dec 2019
407.64M
Maximum
Mar 2021
151.87M
Average
168.68M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.628B |
| Amphastar Pharmaceuticals Inc | 178.13M |
| Nutriband Inc | -4.254M |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 39.66M |
| Cash from Investing (Quarterly) | -6.465M |
| Cash from Financing (Quarterly) | -35.09M |
| Free Cash Flow Per Share (Quarterly) | 0.0884 |
| Free Cash Flow to Equity (Quarterly) | 47.37M |
| Free Cash Flow to Firm (Quarterly) | 82.27M |
| Free Cash Flow Yield | 8.35% |